Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI

Rogers, Brooke G.; Coats, Cassie Sutten; Adams, Emily; Murphy, Matthew; Stewart, Cynthia J.; Arnold, Trisha; Chan, Philip A.; Nunn, Amy

doi:10.1007/s10461-020-02895-1

Cited by 88 publications

(102 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the study [ 32 ], the authors review the transition from a new LGBTQ clinic to telemedicine and the implications for providing HIV prevention and care services during COVID-19. Open Door Health (ODH) is the first clinic dedicated to providing primary and sexual healthcare to the LGBTQ community in Rhode Island.…”

Section: Resultsmentioning

confidence: 99%

Telemedicine and e-Health research solutions in literature for combatting COVID-19: a systematic review

et al. 2021

View full text Add to dashboard Cite

COVID-19 had led to severe clinical manifestations. In the current scenario, 98 794 942 people are infected, and it has responsible for 2 124 193 deaths around the world as reported by World Health Organization on 25 January 2021. Telemedicine has become a critical technology for providing medical care to patients by trying to reduce transmission of the virus among patients, families, and doctors. The economic consequences of coronavirus have affected the entire world and disrupted daily life in many countries. The development of telemedicine applications and eHealth services can significantly help to manage pandemic worldwide better. Consequently, the main objective of this paper is to present a systematic review of the implementation of telemedicine and e-health systems in the combat to COVID-19. The main contribution is to present a comprehensive description of the state of the art considering the domain areas, organizations, funding agencies, researcher units and authors involved. The results show that the United States and China have the most significant number of studies representing 42.11% and 31.58%, respectively. Furthermore, 35 different research units and 9 funding agencies are involved in the application of telemedicine systems to combat COVID-19.

show abstract

Section: Resultsmentioning

confidence: 99%

Telemedicine and e-Health research solutions in literature for combatting COVID-19: a systematic review

et al. 2021

View full text Add to dashboard Cite

show abstract

“…While our results underscore the need for improved messaging around the availability of HIV testing, innovative ways to provide critical HIV prevention services are evolving: Home specimen collection kits and selftests are being made available and telehealth visits (supported by HIPPA compliant technology), accompanied with longer prescription supplies, support continued PrEP use that are but a few examples [6]. However, efforts to appropriately scale these efforts require addressing several potential barriers such as achieving payment parity for telemedicine assessments, develop a unique workflow that clearly identifies if and when an in-person visit is required as well as what labs can (or cannot) be delayed [34]. While the results reported here highlight concerns that require focused responses to address PrEP disruptions, they also suggest potential ways for services to adapt going forward (e.g., telehealth).…”

Section: Discussionmentioning

confidence: 99%

Rapid mixed-methods assessment of COVID-19 impact on Latinx sexual minority men and Latinx transgender women

et al. 2020

View full text Add to dashboard Cite

We conducted a rapid, mixed-methods assessment to understand how COVID-19 affected Latinx sexual minority men (LSMM) and transgender women (LTGW). Using a computer-assisted telephone interviewing software, one interviewer called 52 participants (randomly sampled from a larger HIV prevention pilot study aiming to increase HIV knowledge and testing frequency; n = 36 LSMM and n = 16 LTGW) between 04/27/20-05/18/20. We quantified core domains using the Epidemic-Pandemic Impacts Inventory scale and provided important context through open-ended qualitative questions assessing: 1) COVID-19 infection history and experiences with quarantine; 2) Health and healthcare access; 3) Employment and economic impact of COVID-19. Participants reported increases in physical conflict or verbal arguments with a partner (13.5%) or other adult(s) (19.2%) due to stressors associated with the safer-at-home order. Participants also reported increased alcohol consumption (23.1%), problems with sleep (67.3%) and mental health (78.4%). Further, disruptions in access to Pre-Exposure Prophylaxis or PrEP–a daily pill to prevent HIV–occurred (33.3% of 18 participants who reported being on PrEP). Many said they received less medical attention than usual (34.6%), and LTGW reported delays in critical gender-affirming hormones/procedures. Half of the participants lost their jobs (50.0%); many undocumented participants relayed additional financial concerns because they did not qualify for financial assistance. Though no COVID-19 infections were noted, COVID-19 dramatically impacted other aspects of health and overall wellbeing of LSMM and LTGW. Public health responses should address the stressors faced by LSMM and LTGW during the COVID-19 pandemic and the impact on wellbeing.

show abstract

“…Young et al [36] and Ohl et al [37] both found that, where telemedicine was available to patients, greater viral suppression was achieved. Rogers et al [38] have described an effective implementation of telemedicine in a clinic in the USA, to ensure continuity of care during the COVID-19 pandemic. Clinics who implemented telemedicine also reported fewer missed appointments and higher patient engagement.…”

Section: Telemedicinementioning

confidence: 99%

Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review

et al. 2020

View full text Add to dashboard Cite

Objectives The aim of the study was to systematically review current studies reporting on clinical outcomes in people living with HIV (PLHIV) infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Methods We conducted a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) guidelines. A comprehensive literature search was conducted in Global Health, SCOPUS, Medline and EMBASE using pertinent key words and Medical Subject Headings (MeSH) terms relating to coronavirus disease 2019 (COVID‐19) and HIV. A narrative synthesis was undertaken. Articles are summarized in relevant sections. Results Two hundred and eighty‐five articles were identified after duplicates had been removed. After screening, eight studies were analysed, totalling 70 HIV‐infected patients (57 without AIDS and 13 with AIDS). Three themes were identified: (1) controlled HIV infection does not appear to result in poorer COVID‐19 outcomes, (2) more data are needed to determine COVID‐19 outcomes in patients with AIDS and (3) HIV‐infected patients presenting with COVID‐19 symptoms should be investigated for superinfections. Conclusions Our findings suggest that PLHIV with well‐controlled disease are not at risk of poorer COVID‐19 disease outcomes than the general population. It is not clear whether those with poorly controlled HIV disease and AIDS have poorer outcomes. Superimposed bacterial pneumonia may be a risk factor for more severe COVID‐19 but further research is urgently needed to elucidate whether PLHIV are more at risk than the general population.

show abstract

Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI

Cited by 88 publications

References 12 publications

Telemedicine and e-Health research solutions in literature for combatting COVID-19: a systematic review

Telemedicine and e-Health research solutions in literature for combatting COVID-19: a systematic review

Rapid mixed-methods assessment of COVID-19 impact on Latinx sexual minority men and Latinx transgender women

Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic review

Contact Info

Product

Resources

About